Punch & Associates Investment Management Inc. Makes New Investment in InfuSystem Holdings, Inc. $INFU

Punch & Associates Investment Management Inc. purchased a new stake in shares of InfuSystem Holdings, Inc. (NYSE:INFUFree Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 834,750 shares of the company’s stock, valued at approximately $8,055,000.

A number of other hedge funds have also bought and sold shares of INFU. Quarry LP purchased a new position in shares of InfuSystem in the fourth quarter worth $31,000. Raymond James Financial Inc. purchased a new stake in shares of InfuSystem during the second quarter valued at $33,000. Virtu Financial LLC purchased a new stake in shares of InfuSystem during the fourth quarter valued at $90,000. LPL Financial LLC acquired a new position in shares of InfuSystem in the 4th quarter valued at $92,000. Finally, Jane Street Group LLC purchased a new position in InfuSystem in the 1st quarter worth $96,000. Institutional investors and hedge funds own 71.13% of the company’s stock.

Wall Street Analyst Weigh In

Separately, B. Riley Financial reaffirmed a “buy” rating and set a $20.00 price target (up from $12.00) on shares of InfuSystem in a research report on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $16.67.

Read Our Latest Research Report on InfuSystem

InfuSystem Stock Up 0.2%

InfuSystem stock opened at $12.04 on Thursday. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. InfuSystem Holdings, Inc. has a 52 week low of $7.29 and a 52 week high of $12.97. The business’s 50-day moving average price is $10.37 and its 200 day moving average price is $9.62. The firm has a market cap of $242.99 million, a price-to-earnings ratio of 200.70 and a beta of 1.42.

InfuSystem announced that its Board of Directors has initiated a share buyback program on Tuesday, May 19th that permits the company to buyback $20.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 10.2% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

InfuSystem Company Profile

(Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

Recommended Stories

Want to see what other hedge funds are holding INFU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InfuSystem Holdings, Inc. (NYSE:INFUFree Report).

Institutional Ownership by Quarter for InfuSystem (NYSE:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.